rilimogene galvacirepvec

{
  "id": "MLC-T-ONC-016542",
  "term": "rilimogene galvacirepvec",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA.",
  "abbreviation": "vPSA-TRI",
  "synonyms": [
    "rvaccinia-prostate-specific antigen-TRICOM vaccine",
    "rvaccinia-PSA-TRICOM vaccine",
    "PROSTVAC-V/TRICOM",
    "recombinant vaccinia-PSA(L155)/TRICOM vaccine",
    "PROSTVAC-V"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/rilimogene-galvacirepvec/"
}